As of 2024-07-27, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (13.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.43 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -646.9%.
The range of the Relative Valuation is (11.20) - (13.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 31.6x | 30.8x |
| Forward P/E multiples | 24.5x - 29.6x | 27.4x |
| Fair Price | (11.20) - (13.50) | (13.29) |
| Upside | -560.8% - -655.5% | -646.9% |
| Date | P/E |
| 2024-07-26 | -5.32 |
| 2024-07-25 | -5.32 |
| 2024-07-24 | -5.12 |
| 2024-07-23 | -5.12 |
| 2024-07-22 | -5.28 |
| 2024-07-19 | -5.23 |
| 2024-07-18 | -5.36 |
| 2024-07-17 | -5.74 |
| 2024-07-16 | -5.98 |
| 2024-07-15 | -5.47 |
| 2024-07-12 | -5.50 |
| 2024-07-11 | -5.45 |
| 2024-07-10 | -5.17 |
| 2024-07-09 | -5.41 |
| 2024-07-08 | -5.26 |
| 2024-07-05 | -5.36 |
| 2024-07-03 | -5.17 |
| 2024-07-02 | -5.12 |
| 2024-07-01 | -5.12 |
| 2024-06-28 | -4.86 |
| 2024-06-27 | -5.06 |
| 2024-06-26 | -4.77 |
| 2024-06-25 | -4.58 |
| 2024-06-24 | -4.77 |
| 2024-06-21 | -4.84 |
| 2024-06-20 | -5.01 |
| 2024-06-18 | -5.96 |
| 2024-06-17 | -6.28 |
| 2024-06-14 | -6.55 |
| 2024-06-13 | -6.37 |
| 2024-06-12 | -6.33 |
| 2024-06-11 | -6.35 |
| 2024-06-10 | -6.37 |
| 2024-06-07 | -6.13 |
| 2024-06-06 | -5.41 |
| 2024-06-05 | -5.10 |
| 2024-06-04 | -4.93 |
| 2024-06-03 | -4.90 |
| 2024-05-31 | -4.73 |
| 2024-05-30 | -5.01 |
| 2024-05-29 | -4.75 |
| 2024-05-28 | -4.60 |
| 2024-05-24 | -4.66 |
| 2024-05-23 | -4.93 |
| 2024-05-22 | -5.21 |
| 2024-05-21 | -5.28 |
| 2024-05-20 | -5.43 |
| 2024-05-17 | -5.17 |
| 2024-05-16 | -5.67 |
| 2024-05-15 | -5.04 |